TY  - JOUR
AU  - Gutiérrez-Gutiérrez, B
AU  - Rodríguez-Baño, J
PY  - 2019
DO  - 10.1016/j.cmi.2019.03.030
UR  - http://hdl.handle.net/10668/13828
T2  - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
AB  - Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) are a frequent cause of invasive infections worldwide. Carbapenems are nowadays the most used drugs to treat these infections. However, due to the increasing rates of resistance to...
LA  - en
KW  - Bloodstream infections
KW  - Carbapenems
KW  - Extended-spectrum beta-lactamases
KW  - Mortality
KW  - Treatment
KW  - Urinary tract Infections
KW  - Anti-Bacterial Agents
KW  - Carbapenems
KW  - Enterobacteriaceae
KW  - Enterobacteriaceae Infections
KW  - Humans
KW  - Immunocompromised Host
KW  - Randomized Controlled Trials as Topic
KW  - Urinary Tract Infections
KW  - beta-Lactamase Inhibitors
KW  - beta-Lactamases
TI  - Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients.
TY  - research article
VL  - 25
ER  -